RedHill Biopharma Ltd.
-
Ticker
RDHL
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Tel-Aviv, Israel
RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company, primarily focused on the development and commercialization of clinical late-stage, proprietary drugs for the treatment of gastrointestinal diseases. RedHill commercializes and promotes several gastrointestinal products in the U.S.
REPORT RATINGS
4.8 / 5.0 (114)
RedHill Biopharma Ltd. reports have an aggregate usefulness score of 4.8 based on 114 reviews.
RedHill Biopharma Ltd.
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports